drugset

drugset / Trial / NCT00452608

Statin for Immunomudulation in Sepsis

NCT00452608 ↗

Phase 2 Unknown 80 enrolled Hospital de Clinicas de Porto Alegre

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine whether atorvastatin can improve the inflammatory answer in the septic patients

Timeline

Start: 2006-12
Primary completion: 2009-12
Completion: 2009-12

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Atorvastatin	Small molecule	80 mg	Oral

Indications